Literature DB >> 4541509

In vitro induction of tumor-specific immunity. I. Parameters of activation and cytotoxic reactivity of mouse lymphoid cells immunized in vitro against syngeneic and allogeneic plasma cell tumors.

H Wagner, M Röllinghoff.   

Abstract

Induction of tumor-specific immunity in vitro was accomplished by cocultivation of cortisone-resistant murine thymocytes or spleen cells with irradiated syngeneic plasma cell tumors (PCT). The cytotoxic activity generated could be detected in a short-term (51)Cr-release assay. Optimal cytotoxic activity against PCT-associated transplantation antigens (TATA) was generated after 7 days in culture. Unlike cytotoxic responses to tumor allografts in which the cytotoxic activity was directed against allogeneic transplantation antigens, the cytotoxic activity obtained in the syngeneic tumor system was specific to the immunizing syngeneic PCT. Similar parameters of induction of cytotoxic responses in in vitro tumor allograft responses and in the syngeneic tumor system suggested that both reactions are cell-mediated cytotoxic immune responses. With regard to the magnitude of cytotoxic responses obtained, allogeneic transplantation antigens induced about a 30-fold higher cytotoxic immune response than plasma cell TATA. The results are consistent with the concept that in vitro tumor allograft responses and in vitro responses against TATA of PCT are similar in quality, but differ in the magnitude of the cytotoxic response provoked.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4541509      PMCID: PMC2180543          DOI: 10.1084/jem.138.1.1

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

1.  A transplantable mast-cell neoplasm in the mouse.

Authors:  T B DUNN; M POTTER
Journal:  J Natl Cancer Inst       Date:  1957-04       Impact factor: 13.506

2.  Cancer; a biological approach. I. The processes of control.

Authors:  M BURNET
Journal:  Br Med J       Date:  1957-04-06

3.  Determination of cell viability.

Authors:  J H HANKS; J H WALLACE
Journal:  Proc Soc Exp Biol Med       Date:  1958-05

4.  Tumor immunity to murine plasma cell tumors. I. Tumor-associated transplantation antigens of NZB and BALB-c plasma cell tumors.

Authors:  M Röllinghoff; B T Rouse; N L Warner
Journal:  J Natl Cancer Inst       Date:  1973-01       Impact factor: 13.506

5.  Primary immune response in cultures of spleen cells.

Authors:  J Marbrook
Journal:  Lancet       Date:  1967-12-16       Impact factor: 79.321

6.  Cell-mediated immune response in vitro. I. A new in vitro system for the generation of cell-mediated cytotoxic activity.

Authors:  H Wagner; M Feldmann
Journal:  Cell Immunol       Date:  1972-03       Impact factor: 4.868

7.  Demonstration of cell-bound and humoral immunity against neuroblastoma cells.

Authors:  I E Hellström; K E Hellström; G E Pierce; A H Bill
Journal:  Proc Natl Acad Sci U S A       Date:  1968-08       Impact factor: 11.205

8.  Delayed hypersensitivity and transplantation immunity elicited by soluble antigens of chemically induced tumours in inbred guinea-pigs.

Authors:  H F Oettgen; L J Old; E P McLean; E A Carswell
Journal:  Nature       Date:  1968-10-19       Impact factor: 49.962

9.  Tumour-distinctive cellular immunity to renal carcinoma.

Authors:  J Stjernswärd; L E Almgård; S Franzén; T von Schreeb; L B Wadström
Journal:  Clin Exp Immunol       Date:  1970-06       Impact factor: 4.330

10.  Immunological tolerance in vitro: kinetic studies at the cellular level.

Authors:  E Diener; W D Armstrong
Journal:  J Exp Med       Date:  1969-03-01       Impact factor: 14.307

View more
  7 in total

1.  Different responses of lymphoid cells from tumor-bearing as compared to tumor-immunized mice when sensitized to tumor specific antigens in vitro.

Authors:  M A Kall; I Hellström; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

2.  The differentiation of cytotoxic T lymphocytes in vitro: an ultrastructural study.

Authors:  A Matter; E Simpson
Journal:  Cell Tissue Res       Date:  1976-02-27       Impact factor: 5.249

Review 3.  Modulation of antitumor immunity--immunobiologic approaches.

Authors:  R J North; E S Dye; C D Mills; J P Chandler
Journal:  Springer Semin Immunopathol       Date:  1982

4.  An analysis of T lymphocyte subsets in tumour-transplanted mice on the basis of Lyt antigenic markers and functions.

Authors:  P K Lala; I F McKenzie
Journal:  Immunology       Date:  1982-12       Impact factor: 7.397

5.  Definition of a unique cell surface antigen of mouse leukemia RL male 1 by cell-mediated cytotoxicity.

Authors:  E Nakayama; H Shiku; T Takahashi; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

6.  Antitumor and therapeutic effects of spleen cells from tumor-bearing mice cultured with T cell growth factor and soluble tumor extract.

Authors:  N Kan; K Ohgaki; T Inamoto; H Kodama
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

7.  Cell-mediated immune responses in vitro. I. Suppression of the generation of cytotoxic lymphocytes by concanavalin A and concanavalin A-activated spleen cells.

Authors:  D L Peavy; C W Pierce
Journal:  J Exp Med       Date:  1974-08-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.